A 50 year old male presents to the primary care physician with gradual onset of shortness of breath, headache, and visual disturbances over the past few months. He also reports fatigue, snoring at night, and daytime sleepiness. He has a history of hypertension and type 2 diabetes mellitus, for which he takes amlodipine and metformin. On examination, he has coarse facial features with a prominent forehead and prognathism, along with enlarged hands and feet. Blood pressure is 150/90 mm Hg. Laboratory evaluation shows elevated IGF-1. Oral glucose tolerance test demonstrates failure of growth hormone suppression. Echocardiography shows left ventricular hypertrophy with an ejection fraction of 55 percent. Pituitary MRI reveals a pituitary adenoma. Diagnosis?
Diagnosis is Acromegaly.
1. Definition
Acromegaly is a disorder caused by excess growth hormone secretion in adulthood, most commonly due to a somatotroph adenoma of the anterior pituitary, leading to elevated IGF-1 and progressive tissue overgrowth.
2. Etiology
2.1
Most Common Cause
- Somatotroph pituitary adenoma
2.2
Other Causes
- Ectopic growth hormone
secretion
- Excess growth hormone releasing
hormone (GHRH)
- Iatrogenic growth hormone
excess
2.3
Familial Associations
- MEN 1
- Carney complex
- McCune-Albright syndrome
- Familial acromegaly
3. Pathophysiology
3.1
Core Mechanism
- Excess growth hormone
stimulates hepatic production of IGF-1
- Increased IGF-1 causes soft
tissue and bone overgrowth
3.2
Systemic Effects
- Insulin resistance leading to type 2 diabetes mellitus
- Cardiac remodeling causing biventricular hypertrophy and
dysfunction
- Soft tissue enlargement causing obstructive sleep apnea
4. Clinical Features
4.1
Somatic Features
- Coarse facial features
- Prominent forehead
- Prognathism
- Enlarged hands and feet
- Widely spaced teeth
4.2
Soft Tissue and Skin Changes
- Macroglossia
- Thickened skin
- Hyperhidrosis
- Skin tags
- Deepened voice
4.3
Neurologic and Mass Effect
- Headache
- Bitemporal hemianopia
- Carpal tunnel syndrome
4.4
Metabolic and Systemic
- Hypertension
- Type 2 diabetes mellitus
- Fatigue
- Obstructive sleep apnea
4.5
Cardiovascular
- Left ventricular hypertrophy
- Diastolic dysfunction
- Progression to heart failure
- Arrhythmias and valvular disease
5. Diagnostic Evaluation
5.1
Screening
- Elevated IGF-1
5.2
Confirmatory Test
- Oral glucose tolerance test showing failure of GH suppression
5.3
Imaging
- Pituitary MRI to identify adenoma
5.4
Additional Evaluation
- Assessment of other
pituitary hormones
- Visual field testing
- Screening for diabetes, dyslipidemia,
and sleep apnea
- Consider echocardiography
- Consider colonoscopy based on guidelines
6. Complications
- Cardiovascular disease
- Respiratory complications including sleep apnea
- Diabetes mellitus
- Arthropathy
- Carpal tunnel syndrome
- Increased risk of colonic
adenomas and colorectal cancer
- Thyroid nodules
7. Management
7.1
First Line
- Transsphenoidal surgery for pituitary adenoma
7.2
Medical Therapy
- Somatostatin analogs such as octreotide, lanreotide, pasireotide
- Dopamine agonists such as cabergoline or bromocriptine
- Growth hormone receptor
antagonist such as pegvisomant
7.3
Radiotherapy
- For persistent or recurrent
disease
7.4
Follow Up
- Monitor GH and IGF-1
levels
- Repeat pituitary imaging
- Long term follow up due to risk of relapse
8. Key Clinical Insight
Coarse facial features + enlarged hands and feet + elevated IGF-1 + failure of GH suppression + pituitary adenoma = acromegaly
9. Exam Level Pearls
- IGF-1 is the best screening test
- OGTT confirms the diagnosis
- Somatotroph adenoma is the most common cause
- Transsphenoidal surgery is first line treatment
- Mortality is mainly due to cardiovascular,
respiratory, and neoplastic complications
- Always look for sleep apnea, diabetes, and visual field defects